D-1350-2015 Class III Terminated
FDA drug recall D-1350-2015 was initiated by Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals on Aug 13, 2015 and is designated Class III. Reason for recall: Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling. The recall status is terminated (terminated Aug 21, 2015). Affected quantity: 360 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 26, 2015
- Initiation Date
- Aug 13, 2015
- Termination Date
- Aug 21, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 360 Bottles
Product description
AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma Ireland Ltd., Clonmel, Ireland, NDC: 67253-180-50
Reason for recall
Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.
Distribution pattern
U.S. Including: OH
Code information
Lot #: 52217, Expiry: 04/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1350-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026